Skip to content

Investigator

Christopher L Cunningham

UNIVERSITY OF PITTSBURGH AT PITTSBURGH · funded by NIDCD

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$965k

Summed across those awards.

First award
Jan 6, 2025

Latest May 7, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Critical proteins for hair cell protein trafficking and auditory function

    $659k

    May 7, 2026NIDCDUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11342408 (opens the source filing in a new tab)

  2. R41

    Cell type-specific gene therapy approach for TOMT-linked congenital hearing loss

    $306k

    Jan 6, 2025NIDCDECHOGENESIS THERAPEUTICS INCNIH RePORTER · 11066259 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources